Espifresh Inc. – FDA Warning Letter, Jan 28, 2026

The U.S. Food and Drug Administration (FDA) issued a warning letter to Espifresh Inc., a Los Angeles-based company, following inspections conducted in July 2025 and January 2026. These inspections evaluated the firm"s compliance with the Foreign Supplier Verification Program (FSVP) requirements under the Federal Food, Drug, and Cosmetic Act. The FDA determined that Espifresh Inc. failed to develop and maintain an FSVP for several imported products, including fresh chayote, pacaya, mango, and certain flowers. The FSVP regulation requires importers to perform risk-based activities to verify that foreign-produced food meets U.S. safety standards, specifically those related to produce safety and public health protection. While the company responded to previous warnings by appointing a qualified individual and updating internal procedures, the FDA found the response insufficient because the firm failed to provide actual documentation of these corrective actions. Consequently, the company remains in violation of federal food safety laws. Espifresh Inc. must submit a written response within 15 working days detailing its specific corrective measures and providing supporting documentation, such as completed FSVP records. Failure to rectify these issues may lead to the FDA refusing entry of the company"s imported food products or placing them on a detention list without physical examination.